Clinical Studies

Melanoma Treatment Study

Now Enrolling Patients​

Study Overview 

The primary objective of this study is to confirm that Gilvetmab is safe and effective in dogs diagnosed with malignant melanoma. 

Eligibility Criteria: 

For full inclusion criteria, reach out to the participating hospital directly. 

• Dog is ≥ 1 year of age 
• Dog is ≥ 6.6lbs 
• Dogs diagnosed with malignant melanoma 

Study Timeline 

• 190 days 
• 14 clinic visits over study duration 

Interested in this study?
Reach out to a participating hospital to learn more!

Ethos Hospitals 

Metropolitan Veterinary Hospital: Cleveland, OH 

Summit Veterinary Referral Center: Tacoma, WA 

Veterinary Specialty Hospital: San Diego, CA